U.S. Pharmaceuticals & Biotech Most Popular Stocks

bioAffinity Technologies

Market Cap: US$4.2m

Engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States.

Quoin Pharmaceuticals

Market Cap: US$4.1m

A late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States.

One World Products

Market Cap: US$4.0m

Engages in the provision of renewable and sustainable materials.

Biodexa Pharmaceuticals

Market Cap: US$4.0m

A clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of familial adenomatous polyposis, non-muscle invasive bladder cancer, and Type 1 diabetes and rare/orphan cancers of the brain.

Burzynski Research Institute

Market Cap: US$3.9m

Engages in the research and development of antineoplaston drugs for the treatment of various cancers.

AVVAA World Health Care Products

Market Cap: US$3.9m

Provides natural and therapeutic skin care products worldwide.

Bone Biologics

Market Cap: US$3.9m

A medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein.

Applied DNA Sciences

Market Cap: US$3.8m

A biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally.

Theriva Biologics

Market Cap: US$3.7m

A clinical-stage company, develops therapeutics to treat cancer and related diseases in areas of high unmet need in the United States.

Bio Essence

Market Cap: US$3.5m

Engages in the manufacturing and distributing health supplement products.

Revelation Biosciences

Market Cap: US$3.5m

Operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics.

Dermata Therapeutics

Market Cap: US$3.4m

A late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical skin diseases and aesthetic applications.

Indaptus Therapeutics

Market Cap: US$3.3m

A clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products.

Bespoke Extracts

Market Cap: US$3.3m

Together with its subsidiary, Bespoke Extracts Colorado, LLC, produces and sells pre-rolled marijuana cigarettes in the United States.

SOHM

Market Cap: US$3.3m

Develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States.

CTT Pharmaceutical Holdings

Market Cap: US$3.2m

Engages in the development of oral drug delivery systems for pain management and treatment.

Eastgate Biotech

Market Cap: US$3.2m

A development stage company, develops novel formulations of natural compounds and pharmaceutical products.

PainReform

Market Cap: US$3.0m

A clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel.

GT Biopharma

Market Cap: US$2.8m

A clinical stage biopharmaceutical company, engages in the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) and Tetra-specific Killer Engager (Dual Targeting TriKE) fusion protein immune cell engager technology platforms.

9 Meters Biopharma

Market Cap: US$2.8m

9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders in North America.

Lipella Pharmaceuticals

Market Cap: US$2.8m

A clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications.

Azitra

Market Cap: US$2.6m

An early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases.

Windtree Therapeutics

Market Cap: US$2.6m

A biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases.

Avenue Therapeutics

Market Cap: US$2.5m

A specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases.

Ridder Titan Genesis

Market Cap: US$2.4m

A medical marijuana company, focuses on the development of whole plant extractions for the cancer and palliative treatments.

ProtoKinetix

Market Cap: US$2.4m

A research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs).

Universe Pharmaceuticals

Market Cap: US$2.3m

Through its subsidiaries, engages in the manufacturing, marketing, distribution, and sells of traditional Chinese medicine derivative products in China.

Yubo International Biotech

Market Cap: US$2.3m

Through its subsidiaries, focuses on the research, development, and application of endometrial stem cells.

Panacea Life Sciences Holdings

Market Cap: US$2.2m

Operates as a holding company, researchers, develops, manufactures, produces, and distributes cannabinoids, mushrooms, kratom, and other natural, plant-based ingredients and products for humans and animals.

Silexion Therapeutics

Market Cap: US$2.2m

A biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors.

CDT Equity

Market Cap: US$2.2m

A clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility.

Scinai Immunotherapeutics

Market Cap: US$2.2m

A biopharmaceutical company, focuses on developing, manufacturing, and commercializing inflammation and immunology biological products for the treatment of infectious and autoimmune diseases in Israel.

Salarius Pharmaceuticals

Market Cap: US$2.1m

Operates as a clinical-stage biotechnology company that focuses on developing treatments for cancers with unmet medical need.

SciSparc

Market Cap: US$2.0m

A clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies.

Aoxing Pharmaceutical Company

Market Cap: US$2.0m

A specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People’s Republic of China.

CannaPharmaRX

Market Cap: US$2.0m

Engages in acquisition, development, and operation of cannabis cultivation facilities in Canada.